FDA Drug Application (022081) for LETAIRIS by GILEAD

Back to FDA Applications sponsored by GILEAD

Application Number022081
Product Number001
FormTABLET;ORAL
Dosage5MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameLETAIRIS
Active IngredientAMBRISENTAN



Back to FDA Applications sponsored by GILEAD

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.